Strata advises on the sale of US-based Xceleron Inc. to Pharmaron

Strata Partners is delighted to announce the sale of Xceleron Inc., the Maryland, US-based globally leading Accelerator Mass Spectrometry (AMS) specialist for life sciences, to Pharmaron, a fully integrated contract research organisation offering R&D services for the life science industry with over 4,000 employees, and operations in China, the United States, and the United Kingdom.  Commercial details of the transaction are not being disclosed.